High-risk patients with hypertension: Are we doing enough?

被引:1
|
作者
Chiao, Evelyn [1 ]
Sobolski, John [4 ]
Krienke, Russ [2 ]
Wong, Ken S. [3 ]
Dastani, Homa B. [3 ]
Nightengale, Brian [1 ]
机构
[1] Xcenda, Palm Harbor, FL 34685 USA
[2] Austin Reg Clin, Austin, TX USA
[3] Novartis Pharmaceut, Evidence Based Med, E Hanover, NJ USA
[4] Advocate Hlth Care, Cardiol Sect, Chicago, IL USA
关键词
Blood pressure control; comorbid; obese; advanced age;
D O I
10.1016/j.jash.2008.04.010
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Despite the increasing risk of cardiovascular disease, especially in patients with multiple risk factors, blood pressure (BP) control remains suboptimal. This Study investigated real-world BP goal attainment and prescribing patterns for high-risk patients. A retrospective chart review study was conducted in patients treated by eight large primary care physician group practices between December 2003 and May 2006. A total of 1,917 hypertensive patients were identified with; >= 1 risk factors: African-Amnerican ethnicity (634); diabetes (851); advanced age (1,123); body mass index (BMI) 25 kg/m(2) (1,614). BP control rate was 46% overall, and similar in the advanced age and overweight/obese subpopulations, but substantially lower (28%) in the diabetic subpopulation. Systolic blood pressure; >= 20 mm Hg above the Joint National Committee on Prevention, Detection, Evaluation, and Treatment Report recommendation was found in 13% of the overall, advanced age and overweight/obese subpopulations, and in 20% of diabetics and 18% of African-Americans. Overall, 62% of patients received >= 2 anti hypertensive while 36% of diabetics, 31% of African-Americans, 28% of advanced age, and 26% of overweight/obese patients received >= 3 antihypertensive classes. Despite availability of multiple antihypertensive classes, BP control rates were still suboptimal in this study's high-risk patients. There is a need for awareness and more aggressive treatment in high-risk patients given their increased risk of poor outcomes. J Am Soc Hypertens 2008;2(5): 385-392. (C) 2008 American Society of Hypertension. All rights reserved.
引用
收藏
页码:385 / 392
页数:8
相关论文
共 50 条
  • [31] Management of hypertension during post-stroke rehabilitation: are we doing enough?
    Allen, L.
    Meyer, M.
    Donaldson, S.
    Leci, E.
    Janzen, S.
    Salter, K.
    Teasell, R.
    STROKE, 2012, 43 (11) : E156 - E157
  • [32] Cancer Screening in Patients With Multiple Sclerosis Are We Doing Enough?
    Yang, Jennifer H.
    Graves, Jennifer S.
    NEUROLOGY, 2022, 98 (18) : 737 - 738
  • [33] Readmissions and mortality in pediatric tracheostomy patients: Are we doing enough?
    Tarfa, Rahilla A.
    Morris, Jymirah
    Melder, Katie L.
    McCoy, Jennifer L.
    Tobey, Allison B. J.
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2021, 145
  • [34] Testing for substance use in trauma patients - Are we doing enough?
    London, Jason A.
    Battistella, Felix D.
    ARCHIVES OF SURGERY, 2007, 142 (07) : 633 - 638
  • [35] Management of shoulder dislocation - are we doing enough to reduce the risk of recurrence?
    Davy, AR
    Drew, SJ
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2002, 33 (09): : 775 - 779
  • [36] Effective Management of Cardiovascular Risk Factors-Are We Doing Enough?
    Teo, Koon K.
    Dokainish, Hisham
    CANADIAN JOURNAL OF CARDIOLOGY, 2017, 33 (03) : 300 - 302
  • [37] CHILDHOOD SAFETY - ARE WE DOING ENOUGH
    JACKSON, H
    PRACTITIONER, 1990, 234 (1489) : 524 - &
  • [38] Urological training - are we doing enough?
    Turo, R.
    Bromage, S.
    Esler, R.
    Smolski, M.
    Thompson, A.
    Oakley, N.
    Adeyoju, A.
    Brown, S.
    Brough, R.
    Collins, G.
    BJU INTERNATIONAL, 2014, 113 : 80 - 80
  • [39] Regulation of nanotechnology: Are we doing enough?
    Webster, Thomas J.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2007, 2 (03) : 275 - 276
  • [40] Are We Doing Enough for the Girl Child?
    Upendra Kinjawadekar
    Indian Pediatrics, 2023, 60 : 885 - 886